Medirom Healthcare Technologies Stock Analysis

Medirom Stock Analysis Notes

About 40.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.15. Medirom Healthcare had not issued any dividends in recent years. MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 171 people. To find out more about Medirom Healthcare Technologies contact Kouji Eguchi at 81 3 6721 7364 or learn more at https://medirom.co.jp.

Medirom Healthcare Investment Alerts

Medirom Healthcare Upcoming and Recent Events

Medirom Healthcare Thematic Classifications

Medirom Stock Institutional Investors

Note, although Medirom Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Medirom Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 7.33 M.

Medirom Profitablity

The company has Net Profit Margin of 0.02 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.02) %, which entails that for every $100 of revenue, it lost $0.02.

Management Efficiency

Medirom Healthcare has Return on Asset of (0.036) % which means that on every $100 spent on assets, it lost $0.036. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 1.4695 %, implying that it generated $1.4695 on every 100 dollars invested. Medirom Healthcare's management efficiency ratios could be used to measure how well Medirom Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Medirom Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 23rd of January 2025, Return On Assets is likely to grow to 0.02, though Return On Capital Employed is likely to grow to (0.13). At this time, Medirom Healthcare's Other Current Assets are very stable compared to the past year. As of the 23rd of January 2025, Intangible Assets is likely to grow to about 1.1 B, though Net Tangible Assets are likely to grow to (1 B).

Technical Drivers

As of the 23rd of January, Medirom Healthcare secures the Mean Deviation of 5.23, risk adjusted performance of (0.17), and Standard Deviation of 8.26. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medirom Healthcare, as well as the relationship between them. Please verify Medirom Healthcare mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Medirom Healthcare Technologies is priced some-what accurately, providing market reflects its recent price of 0.94999999 per share. Given that Medirom Healthcare is a hitting penny stock territory we strongly suggest to closely look at its jensen alpha.

Medirom Healthcare Price Movement Analysis

Medirom Healthcare Insider Trading Activities

Medirom Healthcare Outstanding Bonds

Medirom Healthcare Predictive Daily Indicators

Medirom Healthcare Forecast Models

Medirom Healthcare's time-series forecasting models are one of many Medirom Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medirom Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medirom Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medirom shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medirom Healthcare. By using and applying Medirom Stock analysis, traders can create a robust methodology for identifying Medirom entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.